CervoMed Inc.

Historical 13F Holders

Symbol
CRVO
CUSIP
15713L109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 15713L109 since 12/18/2024, newest first.

Filer % of Class Filed
CVI Investments, Inc. 13G/A Amendment 1
0% 8/14/2026
Event 6/30/2026
RA Capital Management, L.P. 13G/A Amendment 4
8.6% 8/14/2026
Event 6/30/2026
Armistice Capital, LLC 13G
9.5% 8/14/2026
Event 6/30/2026
Woodline Partners LP 13G 5.1% 8/14/2026
Event 6/30/2026
Morgan Stanley 13G/A Amendment 2
0.1% 7/8/2026
Event 6/30/2026
CVI Investments, Inc. 13G
5.5% 6/26/2026
Event 6/18/2026
Boger Joshua S 13D/A Amendment 2 20.0% 6/15/2026
Event 6/11/2026
Morgan Stanley 13G/A Amendment 1
8.0% 5/11/2026
Event 3/31/2026
AWM Investment Company, Inc. 13G/A Amendment 1 4.2% 4/7/2026
Event 3/31/2026
Morgan Stanley 13G
5.1% 2/11/2026
Event 12/31/2025
RA Capital Management, L.P. 13G/A Amendment 3
9.9% 8/20/2025
Event 6/30/2025
RA Capital Management, L.P. 13G/A Amendment 2
0% 8/14/2025
Event 6/30/2025
AWM Investment Company, Inc. 13G 9.9% 5/7/2025
Event 3/31/2025
RA Capital Management, L.P. 13G/A Amendment 1
9.9% 2/14/2025
Event 12/31/2024
AWM Investment Company, Inc. 13G/A Amendment 1 4.7% 1/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 50.1 k $147 k
2026 Q2 37 1.75 M $5.42 M
2026 Q1 36 1.77 M $6.97 M
2025 Q4 49 2.20 M $17.4 M
2025 Q3 46 2.13 M $17.3 M
2025 Q2 47 2.18 M $13.7 M
2025 Q1 49 2.28 M $20.9 M
2024 Q4 50 1.49 M $3.46 M
2024 Q3 52 3.51 M $51.2 M
2024 Q2 41 3.46 M $59.2 M
2024 Q1 23 2.51 M $57.2 M
2023 Q4 14 326 k $2.48 M
2023 Q3 13 364 k $1.68 M